MACKENZIE FINANCIAL CORP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$84,666,131
+$17,974,165 QoQ
Shares Held
135,783
+57.3% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#91
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. REGN ranks #1 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,666,131 | 135,783 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $66,691,966 | 86,317 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $60,773,956 | 78,736 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $72,320,854 | 128,623 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $53,244,450 | 101,418 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $42,468,040 | 66,960 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $39,200,944 | 55,032 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $58,861,030 | 55,992 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $60,921,902 | 57,964 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,793,566 | 55,890 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $49,434,552 | 56,285 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $46,370,504 | 56,346 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $42,856,599 | 59,644 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $54,813,605 | 66,710 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $51,910,484 | 71,949 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $56,305,478 | 81,736 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $52,757,170 | 89,248 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $65,588,622 | 93,910 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $55,705,116 | 88,208 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $53,600,792 | 88,570 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $49,403,421 | 88,451 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $33,199,760 | 70,169 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,813,231 | 36,872 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $17,581,010 | 31,407 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,519,819 | 23,282 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,160,808 | 18,761 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||